Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.19 | N/A |
| PEG Ratio (TTM) | -9.38 | N/A |
| P/S Ratio (TTM) | 2.69 | N/A |
| P/B Ratio (TTM) | 1.81 | N/A |
| P/FCF Ratio (TTM) | 8.14 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.85 | N/A |
| Price to 5YR AVG FCF Ratio | 9.01 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.60% | N/A |
| ROE (TTM) | 19.61% | N/A |
| Net Profit Margin (TTM) | 26.55% | N/A |
| ROIC 5YR AVG | 23.94% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.00% | 43.07% | 31.58% |
| Revenue | 1.61% | 13.23% | 700.92% |
| Net Income | -2.56% | 39.64% | 25.35% |
| Cash Flow | 12.52% | 12.50% | 6.02% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.14 | N/A |
| Quick Ratio (TTM) | 0.14 | N/A |
| D/E Ratio (TTM) | 0.36 | N/A |
| Interest Coverage (TTM) | 2.43 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.13 | N/A |
| LTL to 5YR AVG FCF | 1.95 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.85% | N/A |